These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1147 related articles for article (PubMed ID: 33398162)

  • 1. Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.
    Yu J; Green MD; Li S; Sun Y; Journey SN; Choi JE; Rizvi SM; Qin A; Waninger JJ; Lang X; Chopra Z; El Naqa I; Zhou J; Bian Y; Jiang L; Tezel A; Skvarce J; Achar RK; Sitto M; Rosen BS; Su F; Narayanan SP; Cao X; Wei S; Szeliga W; Vatan L; Mayo C; Morgan MA; Schonewolf CA; Cuneo K; Kryczek I; Ma VT; Lao CD; Lawrence TS; Ramnath N; Wen F; Chinnaiyan AM; Cieslik M; Alva A; Zou W
    Nat Med; 2021 Jan; 27(1):152-164. PubMed ID: 33398162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis.
    Luo Z; Jiang M; Cheng N; Zhao X; Liu H; Wang S; Lin Q; Huang J; Guo X; Liu X; Shan X; Lu Y; Shi Y; Luo L; You J
    J Control Release; 2024 Sep; 373():890-904. PubMed ID: 39067794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Receptor Blockade Potentiates Immunotherapy for Liver Metastases by Altering the Liver Immunosuppressive Microenvironment.
    Benslimane Y; Amalfi K; Lapin S; Perrino S; Brodt P
    Cancer Res Commun; 2024 Aug; 4(8):1963-1977. PubMed ID: 39007345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases.
    He K; Barsoumian HB; Bertolet G; Verma V; Leuschner C; Koay EJ; Ludmir EB; Hsu E; Pisipati E; Voss TA; Puebla-Osorio N; Cortez MA; Welsh JW
    Front Immunol; 2021; 12():812210. PubMed ID: 34975924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
    Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
    J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
    Curtis LT; Sebens S; Frieboes HB
    Cancer Immunol Immunother; 2021 May; 70(5):1475-1488. PubMed ID: 33180183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
    Corrao G; Marvaso G; Ferrara R; Lo Russo G; Gugliandolo SG; Piperno G; Spaggiari L; De Marinis F; Orecchia R; Garassino MC; Jereczek-Fossa BA
    Lung Cancer; 2020 Apr; 142():70-79. PubMed ID: 32120227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Zhou SN; Pan WT; Pan MX; Luo QY; Zhang L; Lin JZ; Zhao YJ; Yan XL; Yuan LP; Zhang YX; Yang DJ; Qiu MZ
    Dig Dis Sci; 2021 Feb; 66(2):474-482. PubMed ID: 32193860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y; McCarthy C; Kalirai H; Coupland SE
    Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.
    Martinet O; Divino CM; Zang Y; Gan Y; Mandeli J; Thung S; Pan PY; Chen SH
    Gene Ther; 2002 Jun; 9(12):786-92. PubMed ID: 12040460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 14. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.
    Satoh Y; Esche C; Gambotto A; Shurin GV; Yurkovetsky ZR; Robbins PD; Watkins SC; Todo S; Herberman RB; Lotze MT; Shurin MR
    J Exp Ther Oncol; 2002; 2(6):337-49. PubMed ID: 12440225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
    Grosenbach DW; Barrientos JC; Schlom J; Hodge JW
    Cancer Res; 2001 Jun; 61(11):4497-505. PubMed ID: 11389081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer.
    Deng JY; Gou Q; Yang L; Chen ZH; Yang MY; Yang XR; Yan HH; Wei XW; Liu JQ; Su J; Zhong WZ; Xu CR; Wu YL; Zhou Q
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Efficient Combination Immunotherapy for Primary Liver Cancer by Harmonized Activation of Innate and Adaptive Immunity in Mice.
    Wen L; Xin B; Wu P; Lin CH; Peng C; Wang G; Lee J; Lu LF; Feng GS
    Hepatology; 2019 Jun; 69(6):2518-2532. PubMed ID: 30693544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tumor-infiltrating lymphocytes in the treatment of hepatic metastases arising from transgenic intraocular tumors in mice.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1067-75. PubMed ID: 7730016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.